Fibroblast growth factor 9 activates Akt and MAPK pathways to stimulate steroidogenesis in mouse leydig cells

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Lai, Meng Shao ^a   Cheng, Yu Sheng ^b   Chen, Pei Rong ^a   Tsai, Shaw Jenq ^a   Huang, Bu Miin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 9; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROGESTERONE; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LEYDIG CELL; MALE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; TUMOR CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; IMMUNOBLOTTING; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 9; IMMUNOBLOTTING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEYDIG CELLS; MALE; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROGESTERONE; PROTO-ONCOGENE PROTEINS C-AKT; RAS PROTEINS;

EID: 84897397716     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090243     Document Type: Article

References (40)

1. Naruo K, Seko C, Kuroshima K, Matsutani E, Sasada R, et al. (1993) Novel secretory heparin-binding factors from human glioma cells (glia-activating factors) involved in glial cell growth. Purification and biological properties. J Biol Chem 268: 2857-2864. (Pubitemid 23057920)
2. Cohen RI, Chandross KJ (2000) Fibroblast growth factor-9 modulates the expression of myelin related proteins and multiple fibroblast growth factor receptors in developing oligodendrocytes. J Neurosci Res 61: 273-287. (Pubitemid 30620058)
3. Colvin JS, Green RP, Schmahl J, Capel B, Ornitz DM (2001) Male to female sex reversal in mice lacking fibroblast growth factor 9. Cell 104: 875-889. (Pubitemid 32289280)
4. Lovicu FJ, Overbeek PA (1998) Overlapping effects of different members of the FGF family on lens fiber differentiation in transgenic mice. Development 125: 3365-3377. (Pubitemid 28458336)
5. Reuss B, Hertel M, Werner S, Unsicker K (2000) Fibroblast growth factors-5 and -9 distinctly regulate expression and function of the gap junction protein connexin43 in cultured astroglial cells from different brain region. Glia 30: 231-241. (Pubitemid 30259663)
6. Schreiber NB, Spicer LJ (2012) Effects of fibroblast growth factor 9 (FGF9) on steroidogenesis and gene expression and control of FGF9 mRNA in bovine granulosa cells. Endocrinology 153: 4491-4501.
7. Schreiber NB, Totty ML, Spicer LJ (2012) Expression and effect of fibroblast growth factor 9 in bovine theca cells. J Endocrinol 215: 167-175.
8. Lin YM, Tsai CC, Chung CL, Chen PR, Sun HS, et al. (2010) Fibroblast growth factor 9 stimulates steroidogenesis in postnatal Leydig cells. Int J Androl 33: 545-553.
9. Hiramatsu R, Matoba S, Kanai-Azuma M, Tsunekawa N, Katoh-Fukui Y, et al. (2008) A critical time window of Sry action in gonadal sex determination in mice. Development 136: 129-138.
10. Hiramatsu R, Harikae K, Tsunekawa N, Kurohmaru M, Matsuo I, et al. (2010) FGF signaling directs a center-to-pole expansion of tubulogenesis in mouse testis differentiation. Development 137: 303-312.
11. Chung CL, Lu CW, Cheng YS, Lin CY, Sun HS, et al. (2013) Association of aberrant expression of sex-determining gene fibroblast growth factor 9 with Sertoli cell-only syndrome. Fertil Steril, in press.
12. Saez JM (1994) Leydig cells: endocrine, paracrine, and autocrine regulation. Endocr Rev 15: 574-626.
13. Ascoli M, Fanelli F, Segaloff DL (2002) The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 23: 141-174. (Pubitemid 34299022)
14. Hirakawa T, Galet C, Ascoli M (2002) MA-10 cells transfected with the human lutropin/choriogonadotropin receptor (hLHR): a novel experimental paradigm to study the functional properties of the hLHR. Endocrinology 143: 1026-1035. (Pubitemid 34164051)
15. Brion L, Maloberti PM, Gomez NV, Poderoso C, Gorostizaga AB, et al. (2011) MAPK phosphatase-1 (MKP-1) expression is up-regulated by hCG/cAMP and modulates steroidogenesis in MA-10 Leydig cells. Endocrinology 152: 2665-2677.
16. Ahn SW, Gang GT, Kim YD, Ahn RS, Harris RA, et al. (2013) Insulin directly regulates steroidogenesis via induction of the orphan nuclear receptor DAX-1 in testicular Leydig cells. J Biol Chem 288: 15937-15946.
17. Johnson D, Williams L (1993) Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60: 1-41.
18. Niederst MJ, Engelman JA (2013) Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer. Sci Signal 6: re6.
19. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, et al. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183. (Pubitemid 32458157)
20. Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139-149. (Pubitemid 40616112)
21. Mohammadi M, Honegger AM, Rotin D, Fischer R, Bellot F, et al. (1991) A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol Cell Biol 11: 5068-5078. (Pubitemid 21895268)
22. Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912. (Pubitemid 35425238)
23. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol 8(6): e1000412.
24. Ascoli M (1981) Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology 108: 88-95.
25. Pao HY, Pan BS, Leu SF, Huang BM (2012) Cordycepin stimulated steroidogenesis in MA-10 mouse Leydig tumor cells through the protein kinase C Pathway. J Agric Food Chem 60: 4905-4913.
26. Manna PR, Stocco DM (2011) The role of specific mitogen-activated protein kinase signaling cascades in the regulation of steroidogenesis. J Signal Transduct 2011: 1-13.
27. Wang Q, Leader A, Tsang BK (2013) Inhibitory roles of prohibitin and chemerin in FSH-induced rat granulosa cell steroidogenesis. Endocrinology 154: 956-967.
28. Maillard V, Froment P, Ramé C, Uzbekova S, Elis S, et al. (2011) Expression and effect of resistin on bovine and rat granulosa cell steroidogenesis and proliferation. Reproduction 141: 467-479.
29. Yao B, Liu HY, Gu YC, Shi SS, Tao XQ, et al. (2011) Gonadotropin- releasing hormone positively regulates steroidogenesis via extracellular signal-regulated kinase in rat Leydig cells. Asian J Androl 13: 438-445.
30. Kim JY, Han EH, Kim HG, Oh KN, Kim SK, et al. (2010) Bisphenol A-induced aromatase activation is mediated by cyclooxygenase-2 up-regulation in rat testicular Leydig cells. Toxicol Lett 193: 200-208.
31. Qiao D, Meyer K, Friedl A (2013) Glypican 1 stimulates s phase entry and DNA replication in human glioma cells and normal astrocytes. Mol Cell Biol 33: 4408-4421.
32. Romero I, Bast RC Jr (2012) Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology 153: 1593-1602.
33. Falvella FS, Frullanti E, Galvan A, Spinola M, Noci S, et al. (2009) FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. Int J Cancer 124: 2880-2885.
34. Coffey E, Newman DR, Sannes PL (2013) Expression of fibroblast growth factor 9 in normal human lung and idiopathic pulmonary fibrosis. J Histochem Cytochem 61: 671-679.
35. Guijarro MV, Vergel M, Marin JJ, Muñoz-Galván S, Ferrer I, et al. (2012) p38α limits the contribution of MAP17 to cancer progression in breast tumors. Oncogene 31: 4447-4459.
36. Norman M, Wisniewska KA, Lawrenson K, Garcia-Miranda P, Tada M, et al. (2012) Loss of Scribble causes cell competition in mammalian cells. J Cell Sci 125: 59-66.
37. Matsui Y, Ueda S, Watanabe J, Kuwabara I, Ogawa O, et al. (2007) Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species. Cancer Res 67: 1212-1220.
38. Menon MB, Kotlyarov A, Gaestel M (2011) SB202190-induced cell type-specific vacuole formation and defective autophagy do not depend on p38 MAP kinase inhibition. PLOS One 6: e23054.
39. Muniyappa H, Das KC (2008) Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: A MLK-3-MKK7-dependent mechanism. Cell Signal 20: 675-683.
40. Hirosawa M, Nakahara M, Otosaka R, Imoto A, Okazaki T, et al. (2009) The p38 pathway inhibitor SB202190 activates MEK/MAPK to stimulate the growth of leukemia cells. Leuk Res 33: 693-699.